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INTRODUCTION 
Despite the existence of a safe and effective vaccine, 
Hepatitis B still remains a global public health problem. 
It is a major cause of morbidity and mortality in the 
developing countries. Chronic carriage rates in sub-
Saharan Africa are high.
1
 Hepatitis B carriage in 
pregnancy is of great public health concern. This is 
because it not only exposes their babies to vertical and 
early horizontal transmission but their close contacts and 
delivery care staff are at risk of horizontal transmission.  
Vertical transmission is thought to be a great risk in high 
prevalence regions.
2
 It contributes significantly to the 
pool of chronic HBV carriers who act as a source of 
infection.  
ABSTRACT 
 
Background: Hepatitis B virus belongs to the family Hepadnaviridae. It is the commonest cause of chronic viral 
hepatitis. It is responsible for up to 80% of primary liver cancers. Despite the existence of a safe and effective 
vaccine, HBV infections still remain a global public health problem. Pregnant women who are carriers of the virus 
pose a significant risk to their unborn babies. Early diagnosis in this group can provide an avenue for prevention of 
mother to child transmission which will in turn lead to a reduction in the number of chronic carriers who act as a 
source of new infections.  
Methods: The study was a multicenter, hospital based cross-sectional study. Data collection was using a 
questionnaire-guided interview followed by HBsAg determination using SD bioline test device. Data entry and 
statistical analysis was done using SPSS version 16. A p-value of less than 0.05 was considered significant.  
Results: The prevalence of Hepatitis B among pregnant women in Kigali is 3.1%.The study findings also indicated 
that the mean age of the participants was 28.03 years with a standard deviation of 5.6 years. Majority of the women 
(37.4%) were between 25 and 29 years. About two thirds of the recruited women resided in urban area while a third 
was from rural area. Most of the women (61.3%) had attained primary level formal education with only a few with 
tertiary level education (7.9%). 6% of them had no formal education. Majority of these women (95%) were in 
marriage unions a majority of which were monogamous.    
Conclusions: The findings indicate an intermediate endemicity of HBV among the pregnant women in Kigali at 3.1% 
prevalence, the lowest among the East African countries. This is among the first Hepatitis B prevalence studies 
among the pregnant women, hence it provides baseline data that can be useful in contributing to knowledge of the 
disease characteristics, stimulate further research on the disease and also contribute to informing policy on control 
measures.  
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Universal antenatal screening coupled with passive-active 
immuno-prophylaxis to neonates at birth has been shown 
to reduce risk of mother to child transmission by 95%.
3
 In 
spite of this knowledge, universal ante-natal screening is 
not widely practiced in Africa, including Rwanda. This, 
combined with the fact that the current immunization for 
HBV starts at 6 weeks, possibly exposes a number of 
infants to the risk of perinatal transmission. 
Many studies have suggested that transmission in sub-
Saharan Africa occurs predominantly in childhood.
4
  
hence the need to have control measures targeted at 
reducing this risk including mother to child transmission. 
Parental HBV carriage poses a significant risk to a child.
3
 
Maternal HBV has been associated with adverse 
pregnancy and perinatal outcomes making it important to 
screen and manage it effectively to prevent mother to 
child transmission and avert the adverse outcomes.
5,6 
Knowledge of local prevalence rates among pregnant 
women is necessary for planning for interventional 
programs. The study therefore intends to assess the 
prevalence of HBV infection among pregnant women in 
Kigali as a way of elucidating the importance of mother 
to child transmission in the area. The information 
obtained can be useful in informing policy on 
transmission prevention programs.
 
METHODS 
Study area description 
Kigali province is the smallest of the five provinces in 
Rwanda and covers a total area of 730 square kilometers. 
It has an estimated total population of almost a million 
giving a population density of 1,165.8/km
2
.  The province 
consists of Nyarugenge, Gasabo and Kicukiro districts. 
For each of these districts, the main government district 
hospital was selected as a study site. The selected  
hospitals included; Muhima Hospital in Nyarugenge 
District, Kibagabaga Hospital in Gasabo District and 
Masaka Hospital in Gasabo District. The district hospitals 
serve people from Kigali city and its immediate environs. 
The population attending the ANC clinics is mostly 
middle and low income. Most of the women who seek 
ANC services are on the national social health insurance 
scheme mutuelle de santé whereby the patient pays ten 
percent of the total cost of services received. The clinics 
run daily from Monday to Friday. They are manned by 
qualified nurses who do the normal ANC follow-up and 
care. Each of the hospitals has Obstetrician/ 
Gynaecologist who follows up the women with any 
complications in pregnancy. 
Study design 
The study was a multicenter, hospital-based, cross-
sectional survey. A questionnaire guided interview was 
used to capture sociodemographic characteristics and 
assess for risk factors for HBV infection. SD Bioline test 
device was used to test for HBsAg testing 
Study population 
The study population consisted of all pregnant women 
attending ANC clinics at Mihima Kibagabaga and 
Masaka Hospitals in Kigali during the period of study. 
Inclusion criteria 
 Pregnant women attending ANC clinics at the three 
hospitals. 
 Those who gave their informed consent to participate 
in the study. 
Exclusion criteria 
Pregnant women who had received Hepatitis B 
vaccination in the past. 
Sample size estimation 
 
Where: 
p = expected prevalence or proportion or estimated 
proportion of HBsAg among pregnant women. This is the 
prevalence that will be estimated by the study. 
m= degree of precision or a tolerance error margin or 
width of the confidence interval (a measure precision of 
the estimate). 
z= Z statistic for a level of confidence or is the normal 
distribution critical value for           
                a probability of /2 in each tail.                   
                  For a 95% CI, z=1.96 
For this study, a specified the level of confidence of 95%, 
an error margin of ±5% was considered acceptable, based 
on similar studies elsewhere. The prevalence in Kenya is 
9.3%.
7
 With significant regional variations with 
prevalence ranging from 3.0% in coast general hospital to 
17.3% in Eldoret. These differences could be attributed to 
differences in sociocultural practices and socioeconomic 
status.  
There was no prevalence study that had been done on 
pregnant women in Rwanda. Owing to sociocultural and 
economic differences between the two countries that may 
impact on HBV prevalence and transmission, a 
prevalence of 50% was assumed in calculating the sample 
size. Using this information in the sample size formula 
above a sample of 385 was estimated as the minimal 
necessary to achieve sufficient precision for the estimated 
prevalence. 
2
2
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Sampling method 
Consecutive sampling was used to recruit study 
participants until the required sample size was obtained. 
All the pregnant women who met the inclusion criteria 
were identified from the women attending ANC. After 
identification, the potential study participants were taken 
through the informed consent process whereby the study 
objectives, risks, benefits and study procedures were 
explained in the local dialect, Kinyarwanda. Only those 
who gave their consent were included in the study. 
Study instrument 
The data collection tool that was used is a pre-coded, pre-
tested questionnaire which was also translated into the 
local dialect Kinyarwanda. 
Data collection 
2mls sample of venous blood was obtained from the 
median vein in the antecubital fossa for each of the 
respondents. Blood was collected using vacutainer needle 
gauge 21 into plain vacutainer clot activator tubes. After 
clotting, the serum was extracted and 20 microlitres were 
placed on the specimen well of the Standard Diagnostics 
INC Bioline HBsAg test device. The result was read after 
20 minutes. A positive result was indicated by 
appearance of two distinct red lines, one in the C (control 
region) and another on the T (test) region. A single red 
stripe on the test region meant it was a negative. There 
were no inconclusive/indeterminate results. 
Data management and analysis 
Data was captured into the questionnaire by the principal 
investigator and the research assistants. The collected 
data was coded and entered into Statistical package for 
social scientists (SPSS) version 16. The results were 
subjected to analysis using cross tabulations to explore 
statistical relationships between variables. Chi square test 
was used to explore proportional relationship between 
groups. The level of statistical significance was set at 
p<0.05, providing a 95% confidence interval. 
RESULTS 
Three hundred and eighty five (385) pregnant women 
were recruited from Muhima, Masaka and Kibagabaga 
Hospitals ANC clinics between May and August 2013. 
Of the 385 participants, 76 were from Masaka Hospital, 
119 from Kibagabaga Hospital and 191 from Muhima 
hospital.  
Social demographic characteristics of the study 
participants 
The mean age of the participants was 28.03 years with a 
standard deviation of 5.6 years .The ages ranged between 
15 years and 46 years. Majority of the women (37.4%) 
were between 25 and 29 years.  
 
Figure 1: Age distribution of the study participants. 
Of the women recruited about two thirds of them were 
residing in urban area while a third were from rural area. 
This is representative of Kigali province that has 70% 
urban area coverage and 30% rural area. 
Most of the women (61.3%) had attained primary level 
formal education with only a few with tertiary level 
education (7.9%). 6% of them had no formal education 
Majority of these women (95%) were in marriage unions 
a majority of which were monogamous. Never married 
women accounted for 3% and separated/ divorced/ 
widowed were 1.8%. 
 
Figure 2: Marital status of study participants. 
A large percentage of the women (52%) reported a 
monthly income of less than 10,000 Rwandan francs (15 
USD), a majority of whom were not engaged in any 
income generating activity. 57.9% of the women are 
living below the poverty line of 1USD per day. This is 
similar to the country’s economy where 50 to 60% of the 
general population lives below the poverty line. 
The table below gives a summary of the 
sociodemographic characteristics of the study 
participants. 
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Table 1: Socio-demographic characteristics of the 
study participants. 
Characteristics n % 
Marital status   
Single 12 3.1 
Married monogamous 361 94.3 
Married polygamous 3 0.8 
Widow 3 0.8 
Separated/ divorced 4 1 
Level of formal education(n=382) 
None 23 6 
Primary 234 61.3 
secondary 95 24.9 
University/college 30 7.9 
Resident of responder (n=383) 
Kicukiro 73 19.1 
Nyarugenge 128 33.4 
Gasabo 151 39.4 
Others* 31 8.1 
Responder occupation (n=349) 
Jobless 150 43 
Farmer 21 6 
Employed 178 51 
*Includes districts of residence that are not within Kigali 
Province. 
Obstetric characteristics of study participants 
108 women (30.4%) were primigravida, while for 
majority (51.8%) this was their 2nd to 4th pregnancy. 
Grand multipar accounted for 13.2%. More than half of 
them (55.6%) were in their last trimester of pregnancy. 
Most of the women (77.7%) reported no history of 
previous pregnancy losses, while 3.7% reported multiple 
previous losses. For most women the current pregnancy 
was uneventful (56.4%) and for most others the reported 
complaints were minor mostly lower abdominal pains 
and morning sickness. 8 women (2.1%) reported history 
of gestational diabetes 
Prevalence of HBsAg  
Of the 385 women tested, 12 tested positive for HBsAg, 
giving an overall prevalence of 3.1%. 
Table 2: Prevalence of HBsAg. 
 Frequency Percentage (%) 
HBsAg  Positive  12 3.1 
HBsAg Negative 373 96.9 
Total 385 100 
HBsAg positivity was highest among the 35-39 years age 
group where the age group prevalence was 4.5%.  
Higher levels of prevalence were obtained in women with 
higher levels of education. Those with tertiary education 
had 6.6% prevalence while the women with primary level 
education had the lowest prevalence at 1.7%. The higher 
prevalence among the group with tertiary education could 
be due to the fewer number of women in this category 
(7.9%). Prevalence of HBsAg among the HIV infected 
was 5.3%. Additionally the prevalence of HBsAg among 
those who previously had STs was 9% while among 
those who never had STIs was 2%. 
Table 3: Prevalence of HBsAg among different 
subpopulations. 
Characteristics N 
No. of 
positives 
Prevale
nce 
Age group (n=385)    
20-24 years 86 2 2.3 
25-29 years 149 5 3.4 
30-34 years 77 3 3.9 
35-39 years 44 2 4.5 
Study site (n=385)    
Kibagabaga 119 5 4.2 
Masaka 76 1 1.3 
Muhima 191 6 3.1 
Residential area  (n=385) 
Urban 251 10 4 
Rural 134 2 1.5 
Level of formal education  (n=382) 
None 23 1 4.3 
Primary 234 4 1.7 
Secondary 95 5 5.2 
University/college 30 2 6.7 
HIV status (n=350)    
Negative 331 9 2.6 
Positive 19 1 5.3 
Not done 35 2 5.7 
Previous history of STIs (n=366) 
No 328 9 2.7 
Yes 38 2 5.3 
DISCUSSION 
The results of the study showed that the prevalence of 
HBsAg among pregnant women attending government 
ANC facilities was 3.1%. According to WHO Kigali has 
intermediate endemicity of HBV infection. The results 
are identical to those found by Rwanda Biomedical 
Centre in the countrywide surveillance done in 2012 in 
government health centers. This intermediate endemicity 
means that most infections could occur in infants and 
children as a result of maternal-neonatal transmission or 
close childhood contact, although percutaneous exposure 
with contaminated needles or following unsafe injections 
is also a possibility. Considering the status of these 
women is usually unknown prenatally, the health care 
workers especially the delivery staff are also at risk of 
percutaneous infection.This calls for more control 
measures in addition to the existing childhood 
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vaccination offered from six weeks by the expanded 
program of immunization. 
Although this prevalence of HBV is similar to the 
prevalence of HIV in the general population which stands 
at 2.9% according to UNAIDS 2012 estimates, the 
HIV/HBV co-infection rates were low with only one 
patient(0.26%) having both HIV and HBV. This 
corroborates what other studies have found (Mali 0.38%)
 
and explains why on further analysis, HIV status was not 
related to HBsAg positivity.
8 
This 3.1% HBV prevalence among pregnant women in 
Kigali is lower than what other studies done on pregnant 
women in East Africa have reported. In Kenya studying 
pregnant women attending various government ANC 
facilities found countrywide prevalence of 9.3%, with 
regional variations.
7
 Rift Valley had the highest 
prevalence of 17.8% in Eldoret while Coast province had 
the lowest prevalence at 3.0%. In Sudan
 
found 5.6% 
prevalence in 2007 reported a prevalence of 4.3% in 
Tanzania in 1994 in 2007 reported 4.9% in Uganda.
9-11 
Studies from West Africa have also generally reported 
higher prevalence’s of HBV among pregnant women 
compared to those of East Africa.
12
 in Nigeria found 
8.3% in 2011, while  in Mali reported a prevalence of 
8.0% in 2012.
8 
The difference in the prevalence of 
hepatitis B between different countries is probably 
indicative of the disparate rates of contact with risk 
factors. This lower prevalence in Kigali could be due to 
differences in sociocultural practices that have been 
linked to HBV transmission, most notably the absence of 
female genital mutilation in Rwanda that is practiced 
widely in Western and Eastern African communities. 
Also the majority of the study participants in this study 
were in monogamous marriages making them a low risk 
group. The other East African studies were carried out 
more than seven years prior to this study and this may 
explain the lower prevalence which may be due to a 
general downward trend of HBV with control measures 
having been increasingly adopted. 
The demographic characteristics of the study populations 
are similar to other populations that have been studied 
elsewhere. Most of the studies report the mean age of the 
study subjects to be between 25 to 28 years. This is 
expected because majority of women in the child bearing 
age are in their twenties .The highest prevalence in this 
study was reported in the 25-29 age group which is 
higher than what found in Nigeria to be the 20-24 age 
group but identical to the ages reported by also in 
Nigeria.
12,13
 He also noted that higher HBV prevalence 
occurred in women of low parity, an observation that is 
also made in this study.  
The higher prevalence in those residing in urban area 
compared to rural residents is in contrary to findings in 
South Africa where rural residents tend to have higher 
prevalence than urban residents as observed by.
14
 
Different rural living conditions could explain the 
differences with South African rural inhabitants living in 
overcrowded villages where risk factors thrive, hence 
exposing the inhabitants. Rural areas of Rwanda are less 
populated compared to urban areas hence transmission is 
higher in the urban set up. 
Assessment of various risk factors for HBV infection in 
this study did not show any statistically significant 
correlations. This is not surprising as studies on 
epidemiological assessment of risk factors for HBV 
infection in low resource set ups seem to yield different 
results. The lack of association between HBV infection 
and known risk factors for infection was also the case in 
the Malian study by
 
and in Sudan, both studying women 
attending ANC clinics.
8,9
 On the contrary, in south East 
Nigeria found that increasing parity, higher number of 
sexual partners, polygamy and history of previous STIs 
were positively associated with HBV in pregnancy (p 
value<0.001).
15
 In addition, studies from India and 
Singapore  have reported positive association with older 
age, gravida two or more, a history of blood transfusion, 
history of HBV infection in family member, history of 
tattooing, previous surgical procures including dilatation 
and curettage for miscarriage and history of blood 
transfusion.
16,17
 
CONCLUSION  
This study was set out to determine the prevalence of 
HBV infection among pregnant women in Kigali. The 
findings indicate an intermediate endemicity of HBV 
among the pregnant women in Kigali at 3.1% prevalence, 
the lowest among the East African countries. This is 
among the first Hepatitis B prevalence studies among the 
pregnant women, hence it provides baseline data that can 
be useful in contributing to knowledge of the disease 
characteristics, stimulate further research on the disease 
and also contribute to informing policy on control 
measures. 
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